Sell the visit, not the drug.
Weight loss clinics can advertise the visit on Meta to adults 18 and older, and on Google, where telehealth prescribing needs certification first. On Meta, naming the drug takes LegitScript and Meta's authorization; TikTok bars creator posts for clinics.
5.0 on Google, 11 reviews
- 5.0 on Google, 11 reviews
Pelora Marketing does absolutely incredible work.
Melissa B., Google review- $5M+ad spend managed
- $15M+raised across his own companiesFounder Preston Durnford
For a medical weight loss clinic, a compliant ad sells the visit, the clinician and the program, to adults 18 and older on Meta. A Meta ad names the drug only with LegitScript certification and Meta's written authorization, which Meta grants only to online pharmacies, telehealth providers and manufacturers; a Google ad may name it in US ad copy, but bidding on it takes certification. A compounded GLP-1 is never called generic, the same as a brand, or FDA-approved, and a patient story over 15 pounds carries what patients typically lose. On TikTok, creators cannot promote a weight loss clinic at all.
- The consult
- The labs
- The clinician
- Adults 18 and older
- Semaglutide
- Tirzepatide
- Ozempic and Wegovy
Four rules on every GLP-1 ad.
- Program or drugOn Meta, only the drug ad needs LegitScript and Meta's authorization. On Google, prescribing by telehealth needs LegitScript and Google's certification before any ad runs.
- 18+18-plus on every weight loss ad on Meta, and on any weight loss claim on TikTok.
- CompoundedCompounded is never "generic", "the same as" a brand, "FDA-approved", or from an "FDA-approved pharmacy".
- TestimonialsA testimonial over 15 pounds, or two pounds a week for a month, carries what patients typically lose. "Results not typical" is not enough.

Five lines that get flagged.
- A statement about their body. Meta bans weight loss ads with "statements of inferiority about physical appearance".
- Pinched fat. Meta bans weight loss ads that show a "Close up on specific body area by pinching fat".
- A deadline on the result. "Down 20 pounds by summer" is a specific outcome in a set timeframe, which Meta bans without a qualifier. TikTok bans suggesting weight loss is "easy or guaranteed".
- The drug, without the paperwork. Bidding on semaglutide, tirzepatide, Ozempic or Wegovy needs Google certification.
- Compounded sold as the brand. FDA's June 8, 2026 warning letter quoted one telehealth company's line "offers the same results but at a fraction of the cost of brand names such as Ozempic, Mounjaro & Wegovy".
What each platform says, word for word.
Program ad or drug ad: what changes
Read at the source, 26 September 202618-plus. No written authorization needed to promote telehealth services generally.
Everything on the left, plus LegitScript, Meta's authorization and a disclaimer to consult a licensed health professional.
Search on the visit and the program. A clinic that prescribes by telehealth needs LegitScript and Google's certification first.
The drug name can appear in US ads and pages; bidding on it needs certification.
Weight claims 18-plus only, and no claim the product alone does it.
TikTok's ad policy does not allow drugs for the purpose of weight loss.
No certification fee for an in-person clinic. A clinic that prescribes by telehealth pays LegitScript's fees (right) before its Google ads run.
LegitScript: $975 per website to apply, then $2,150 a year, and $2,500 more for expedited review.
Program ad or drug ad? We read the ad, the page and every drug name before anything spends.
Book a CallOne line decides it.
Meta bans questions "that are negative and attack an individual's appearance, specific body parts, or hygiene." Its personal attributes rule also bans copy that implies it knows the viewer's health, so "Hate your belly?" breaks the first rule, and in our reading "Tired all the time?" breaks the second, while "Medical weight loss, led by a clinician" runs. Both ads are illustrations, not a client's account.
Every weight loss post, read by a person.
A person reads every ad and creator post against Meta's two policies, Google's drug list, TikTok's rules and FDA's compounded drug claims, two rounds, before permission is requested. For prescription products it is a drug-ad review, so a creator program for one adds $1,000 a month.
- ClaimsNo cure, reverse or guarantee.
- ConsentWritten marketing authorization from every patient shown, separate from treatment consent, on file with the ad.
- DisclosureA patient given a free month or discount says so; the FTC counts that as a material connection.
- The pageThe landing page says what the monthly price covers. The FTC alleged one GLP-1 program advertised $138 or $188 a month without saying the drug, labs and consult cost extra.

Newport Beach office. Clients anywhere.
For online pharmacies, Google suspends accounts without warning for "Targeting locations where you are not licensed", and a telehealth program advertises only where its prescribers are licensed. We work remote from Newport Beach with clinics nationwide.
Asked by weight loss clinics.
What is Meta's advertising policy for medical weight loss ads in 2026?
How do we get a weight loss ad approved on Facebook?
Can a weight loss clinic run Google Ads?
Can we run before-and-after photos for weight loss?
Can we say compounded semaglutide is the same as Ozempic?
Can creators promote our weight loss clinic on TikTok?
Do we need LegitScript for a weight loss clinic?
Do you work with medical weight loss clinics outside California?
Sources, all read on September 26, 2026: Meta Transparency Center, Health and Wellness (change log Jul 22, 2026) and Drugs and Pharmaceuticals; Google Ads, Restricted drug terms, the prescription drug list, Healthcare and medicines, and Unauthorized pharmacies; TikTok Weight Management and Body Image (September 2026), Healthcare and Pharmaceuticals (September 2026), Misleading and False Content (April 2026), Dangerous Products or Services (April 2025) and the Branded Content Policy (effective August 31, 2026); FDA release of March 3, 2026, FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs (current as of June 15, 2026), warning letter 728274 of June 8, 2026, and the September 9, 2025 advertising release; FTC Gut Check, Endorsement Guides (16 CFR 255), and the NextMed complaint (July 2025) and final order (December 2025); LegitScript healthcare certification fees.
Get the account read first.
Fifteen minutes. Bring the rejected ad, or the one you are afraid to run. We will name the line and what runs instead.
5.0 on Google, 11 reviews
